NMFC

Insider Buying Week 11-15-24- Animal Spirits are Back!

by

After weeks of nonexistent insider buying, other than hedge funds which I generally dismiss as informed but not that meaningful OPM other people’s money, insiders have come back with a vengeance.  Some likely unleashed by Trump’s change of regime optimism, while others were likely motivated as the market prematurely selected winners and losers. Centene insiders began buying shares shortly after the election results raised concerns about government funding for healthcare. Enphase, already struggling, faced further declines as solar energy incentives came into question. Meanwhile, semiconductor stocks, with the sole exception of Nvidia, are dropping sharply due to the potential reintroduction … Read more

Insider Buying Week 11-08-24

by

We are in a malaise. It’s that period when most insiders are restricted from trading in their company’s stock due to the upcoming quarterly earnings. But let’s not kid ourselves. Name: Abhijit Y Talwalkar Position: Director Transaction Date: 2024-11-04 Shares Bought: 6,664 Average Price Paid: $75.16 Cost: $500,866 Company: iRhythm Technologies Inc. (IRTC) iRhythm Technologies, Inc., founded in 2006, is headquartered in San Francisco, California. iRhythm Technologies, Inc. is a digital healthcare firm that designs, develops, and commercializes device-based technologies for ambulatory cardiac monitoring and arrhythmia diagnosis in the United States. It provides Zio services, which are ambulatory monitoring solutions … Read more

‘s 5% Decline

by

  Curious how well insiders are doing with their buys? Scroll through the significant buys of the last year. The S&P 500 lost over 6% points last week after losing 5% in the previous week. Stocks don’t fall like this unless there is something really wrong. I’m trying to figure that out and the only thing that I can come up with is that the Fed has been bullied into raising interest rates into a weakening economy. Raising interest rates to bring down the price of oil or to untangle the supply chain disruptions is an act of lunacy.  The … Read more

Insider Buying Week 5-20-22 Trying to Go Up on a Down Escalator

by

  Curious how well insiders are doing with their buys? Scroll through the significant buys of the last year. I spent much of last weekend toiling over the Insiders Report.  Insider buying is picking up in the ruins of the NASDAQ but not enough to waive the all-clear flag that I described in the last post.  The  S&P 500 dipped into “bear” territory Friday only to stage a furious machine-driven short-covering rally that erased a 560 point decline in the last 30 minutes of the day.  Read on for the brave souls that keep trying to ride up the down … Read more

Riots, Protests, Pandemics and a Little Insider Buying Week Ending June 5th, 2020

by

The monster purchase by Mitchell Rales of 141,20 shares of Danaher Corp DHR at $164.69 represented just 0.4% change in his holdings.  If an insider is doubling his holdings, this likely has more significance than just upping your holdings by 4/10 tenths of a percent, but this was still a monster buy and I wanted to analyze it. Danaher has made the Rales brothers billionaires and it seems they are none to eager to unload it. Not sure what to make of Director Glazer’s purchase of $1.7 Million of HCHC.  HC2 Holdings is a publicly traded investment vehicle with Philip … Read more

Quiet Insider Buying Shortened Week May 29th 2020

by

Jazz Pharmaceutical Director Seamus Mulligan bought 50,000 shares at $111.08. Before investors pile in behind that enforcement, it’s worth considering Mulligan bought 50,000 shares back in 11/15/18 at $144.56. JAZZ had a few analyst downgrades after releasing last quarter’s earnings report. JAZZ is a leader in sleep medicine and has a growing hematology/oncology portfolio. Dynavax Technologies DVAX is a startup biotech.  The priced a 14M share offering at $5 below the last closing price osf $5.66. Director Jack bought 1,000,000 shares at $5. Do you think he knew that DVAX would announce a week letter that Sky would report a … Read more

Mercury General Auto Insurer Chairman Puts the Petal to the Metal

by

 Mercury General Chairman George Joseph buys $9.2 Million more of this California property and casualty insurer.  MCY  with a current 6.4% dividend yield and a 34 year history of consecutive dividend raises, looks particularly tempting.  It’s off 44% from its high and the Chairman of the Board has bought $24 million worth of the company’s stock in the last 10 days. People are driving less, auto claims are down. The potential loss of reinvestment income due to lower bond rates seems overstated by this drop in price. Besides Mercury has been historically a  relatively bigger player in the equity markets, … Read more

Insider Buying Picks Up- Week Ending 5-15-20

by

Insider buying picked up this week across several depressed sectors like insurance,  small regional banks,  gaming, furniture, REITS, building products, restaurants and retailers, automotive and motorcycle and utility stocks. The buy of the week is property and casualty California auto insurer, Mercury General MCY.  Chairman of the Board George Joseph continued accumulating stock with $15 million of stock purchases at an average price of $35.95. MCY is down from it’s high this year of $52.  MCY yields 6.65%. People are driving less and insurance claim losses are down  as a result of that. Offsetting this, reinvestment rates on bond portfolios … Read more